Skip to content

A Systems-Level Therapeutic Platform Integrating Neural Progenitors, Mitochondrial Medicine, and Organ-Specific Biologics

We are pleased to share our latest review article exploring a new systems-level approach to one of regenerative medicine’s most complex challenges: spinal cord injury (SCI).

About the Publication:

Spinal cord injury is not simply a localized neurological lesion. It involves a complex network of interconnected challenges, including neuronal loss, mitochondrial dysfunction, chronic inflammation, vascular compromise, extracellular matrix remodeling, and failure of endogenous repair. This complexity may help explain why single-modality regenerative approaches have struggled to produce consistent functional recovery.

This review proposes a systems regeneration framework that brings together three complementary therapeutic pillars:

  • Developmentally specified neural precursor/progenitor cells to support circuit reconstruction, remyelination, and host–graft integration
  • Mitochondrial-directed therapeutics to restore cellular bioenergetics, reduce oxidative stress, and enhance the survival of both native and transplanted cells
  • Organ-specific regenerative biologics, including Nano Organo Peptides (NOPs) and Mito Organelle (MO) preparations, designed to support tissue-specific signaling involved in inflammation, angiogenesis, extracellular matrix remodeling, metabolism, and endogenous repair.

Why It Matters

Rather than targeting a single pathway, this framework views SCI as a systems-level failure of regeneration that may require coordinated restoration of developmental identity, mitochondrial competence, and a supportive regenerative microenvironment.

The article presents the European Wellness regenerative platform as a hypothesis-driven translational model integrating these complementary strategies, while emphasizing that further molecular characterization, standardized potency testing, biomarker development, and controlled clinical trials are needed to validate its therapeutic potential.

A Systems-Level Therapeutic Platform Integrating Neural Progenitors, Mitochondrial Medicine, and Organ-Specific Biologics

by

Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza, and Jonathan RT Lakey

Journal of Stem Cell Research; 7(2), 2026
https://doi.org/10.52793/JSCR.2026.7(2)-90

55 Downloads
Share this post:
Back To Top